or Try an Advanced Search...

    Technical Analysis for XLO - Xilio Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 1.13 -0.88% -0.01
    XLO closed up 5.56 percent on Friday, May 17, 2024, on 7 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical XLO trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish -0.88%
    20 DMA Resistance Bearish 4.63%
    50 DMA Support Bullish 4.63%
    Spinning Top Other 4.63%
    20 DMA Resistance Bearish 0.89%
    Narrow Range Bar Range Contraction 0.89%
    20 DMA Resistance Bearish 3.67%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.67%
    Inside Day Range Contraction 3.67%
    Wide Bands Range Expansion 3.67%
    Older End-of-Day Signals for XLO ...

       Recent Intraday Alerts

    Alert Time
    Fell Below 20 DMA about 1 hour ago
    20 DMA Support about 1 hour ago
    Down 3% about 1 hour ago
    Down 2 % about 1 hour ago
    Down 1% about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    XLO Chart by TradingView
    Basic chart:

    Profile

    Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune system for cancer patients. Its checkpoint inhibitor programs include XTX101, is a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1 clinical trials in patients with solid tumors; and cytokine programs comprise XTX202, XTX301, and XTX401, which are modified form of IL-2 that is masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Solid Tumors Immune System Immunotherapy Tumor Cancer Immunotherapy Immunotherapies Immune Checkpoint Checkpoint Inhibitor Tumor Microenvironment

    Is XLO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 14 Xilio Therapeutics GAAP EPS of -$0.62
    May 14 Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
    Apr 16 Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
    Apr 1 Xilio Therapeutics reports Q4 results
    Apr 1 Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
    Apr 1 Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
    Mar 28 Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 Results
    Mar 28 Xilio stock jumps on Gilead Sciences license deal
    Mar 28 Xilio Therapeutics announces $11.3 million private placement equity financing
    Mar 28 Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
    See more XLO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.25
    52 Week Low 0.49
    Average Volume 1,460,273
    200-Day Moving Average 1.40
    50-Day Moving Average 1.06
    20-Day Moving Average 1.12
    10-Day Moving Average 1.17
    Average True Range 0.13
    RSI (14) 50.98
    ADX 19.61
    +DI 19.52
    -DI 20.03
    Chandelier Exit (Long, 3 ATRs) 0.93
    Chandelier Exit (Short, 3 ATRs) 1.34
    Upper Bollinger Bands 1.27
    Lower Bollinger Band 0.97
    Percent B (%b) 0.56
    BandWidth 27.13
    MACD Line 0.01
    MACD Signal Line 0.03
    MACD Histogram -0.013
    Fundamentals Value
    Market Cap 31.38 Million
    Num Shares 27.5 Million
    EPS -2.96
    Price-to-Earnings (P/E) Ratio -0.39
    Price-to-Sales 0.00
    Price-to-Book 0.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.32
    Resistance 3 (R3) 1.31 1.25 1.29
    Resistance 2 (R2) 1.25 1.20 1.25 1.28
    Resistance 1 (R1) 1.19 1.17 1.22 1.20 1.27
    Pivot Point 1.13 1.13 1.14 1.13 1.13
    Support 1 (S1) 1.07 1.08 1.10 1.08 1.01
    Support 2 (S2) 1.01 1.05 1.01 1.00
    Support 3 (S3) 0.95 1.01 0.99
    Support 4 (S4) 0.96